Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The bevacizumab experience in advanced renal cell carcinoma.

The bevacizumab experience in advanced renal cell carcinoma. Onco Targets Ther. 2010 Oct 05; 3:179-89.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.